Alnylam Pharmaceuticals
ALNY
#554
Rank
NZ$74.04 B
Marketcap
NZ$558.27
Share price
-3.01%
Change (1 day)
21.07%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company